Zonisamide and blood lactate dehydrogenase increased Patient Reports February 12, 2012

Zonisamide Side Effects Report #5652124-9
Zonisamide side effect was reported by a Physician from JAPAN on Feb 25, 2008. Male patient, 71 years of age, was diagnosed with epilepsy  and was treated with Zonisamide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, atelectasis, blood lactate dehydrogenase increased, blood urine present, gamma-glutamyltransferase increased, human herpesvirus 6 infection, pneumonia , toxic epidermal necrolysis. Zonisamide dosage: 300 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.

Zonisamide Side Effects Report #5328638-8
Zonisamide side effect was reported by a Physician from JAPAN on Apr 26, 2007. Male patient, 51 years of age, was diagnosed with cerebral haemorrhage, hypertension and was treated with Zonisamide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood lactate dehydrogenase increased, pyrexia, toxic epidermal necrolysis, white blood cell count increased. Zonisamide dosage: 200 MG, 2 IN 1 D, ORAL. During the same period patient was treated with DIOVAN, LANSOPRAZOLE, PURSENNID. Patient was hospitalized. Patient recovered.

Zonisamide Side Effects Report #5335415-0
Zonisamide side effect was reported by a Physician from JAPAN on Apr 26, 2007. Male patient, 51 years of age, was diagnosed with cerebral haemorrhage, hypertension and was treated with Zonisamide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood lactate dehydrogenase increased, dermatitis exfoliative, pyrexia, stevens-johnson syndrome, toxic epidermal necrolysis. Zonisamide dosage: 200 MG, 2 IN 1 D, ORAL. During the same period patient was treated with DIOVAN, TAKEPRON, PURSENNID. Patient was hospitalized. Patient recovered.

Zonisamide Side Effects Report #5339866-X
Zonisamide side effect was reported by a Physician from JAPAN on May 18, 2007. Male patient, 51 years of age, was diagnosed with cerebral haemorrhage, hypertension and was treated with Zonisamide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood lactate dehydrogenase increased, no therapeutic response, toxic epidermal necrolysis. Zonisamide dosage: 200 MG, 2 IN 1 D; ORAL. During the same period patient was treated with DIOVAN, TAKEPRON, PURSENNID. Patient was hospitalized. Patient recovered.


Zonisamide Side Effects Report #5367696-1
Zonisamide side effect was reported by a Physician from JAPAN on June 05, 2007. Male patient, 51 years of age, was diagnosed with cerebral haemorrhage, hypertension and was treated with Zonisamide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood lactate dehydrogenase increased, dermatitis exfoliative, hypoalbuminaemia, infection , mycoplasma infection, no therapeutic response, staphylococcal infection , toxic epidermal necrolysis. Zonisamide dosage: 200 MG, 2 IN 1 D, ORAL. During the same period patient was treated with DIOVAN, LANSOPRAZOLE, PURSENNID. Patient was hospitalized. Patient recovered.

Zonisamide Side Effects Report #5374123-7
Zonisamide side effect was reported by a Physician from JAPAN on June 20, 2007. Male patient, 51 years of age, was diagnosed with cerebral haemorrhage, hypertension and was treated with Zonisamide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood lactate dehydrogenase increased, cerebral haemorrhage, hypoalbuminaemia, infection , stevens-johnson syndrome, toxic epidermal necrolysis. Zonisamide dosage: 200 MG, 2 IN 1 D, ORAL. During the same period patient was treated with DIOVAN, TAKEPRON, PURSENNID. Patient was hospitalized. Patient recovered.

Zonisamide Side Effects Report #5339866-X
Zonisamide side effect was reported by a Physician from JAPAN on May 18, 2007. Male patient, 51 years of age, was diagnosed with cerebral haemorrhage, hypertension and was treated with Zonisamide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood lactate dehydrogenase increased, no therapeutic response, toxic epidermal necrolysis. Zonisamide dosage: 200 MG, 2 IN 1 D; ORAL. During the same period patient was treated with DIOVAN, TAKEPRON, PURSENNID. Patient was hospitalized. Patient recovered.